249 related articles for article (PubMed ID: 12182046)
21. [The value of a new IRMA for determining thyroglobulin].
Heinze HG; Rall M
Nuklearmedizin; 1992 Oct; 31(5):172-7. PubMed ID: 1465354
[TBL] [Abstract][Full Text] [Related]
22. High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients?
Trimboli P; La Torre D; Ceriani L; Condorelli E; Laurenti O; Romanelli F; Ventura C; Signore A; Valabrega S; Giovanella L
Horm Metab Res; 2013 Sep; 45(9):664-8. PubMed ID: 23720229
[TBL] [Abstract][Full Text] [Related]
23. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
Weightman DR; Mallick UK; Fenwick JD; Perros P
Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
[TBL] [Abstract][Full Text] [Related]
24. Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact.
Iervasi A; Iervasi G; Carpi A; Zucchelli GC
Biomed Pharmacother; 2006 Sep; 60(8):414-24. PubMed ID: 16959467
[TBL] [Abstract][Full Text] [Related]
25. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
Zöphel K; Wunderlich G; Smith BR
Thyroid; 2003 Sep; 13(9):861-5. PubMed ID: 14588100
[TBL] [Abstract][Full Text] [Related]
26. Patients with differentiated thyroid cancer have a venous gradient in thyroglobulin levels.
Kebebew E; Reiff E
Cancer; 2007 Mar; 109(6):1078-81. PubMed ID: 17279579
[TBL] [Abstract][Full Text] [Related]
27. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
[TBL] [Abstract][Full Text] [Related]
28. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
Aras G; Gültekin SS; Küçük NO
Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two thyroglobulin immunoradiometric assays on the basis of comprehensive imaging in differentiated thyroid carcinoma.
Mikosch P; Gallowitsch HJ; Kresnik E; Unterweger O; Gomez I; Lind P
Thyroid; 1999 Sep; 9(9):933-41. PubMed ID: 10524573
[TBL] [Abstract][Full Text] [Related]
30. Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer.
Lombardi CP; Bossola M; Princi P; Boscherini M; La Torre G; Raffaelli M; Traini E; Salvatori M; Pontecorvi A; Bellantone R
Am J Surg; 2008 Sep; 196(3):326-32. PubMed ID: 18614150
[TBL] [Abstract][Full Text] [Related]
31. Serum thyroglobulin measurements in differentiated thyroid cancer.
Girelli ME; De Vido D
Biomed Pharmacother; 2000 Jul; 54(6):330-3. PubMed ID: 10989968
[TBL] [Abstract][Full Text] [Related]
32. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.
Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA
Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179
[TBL] [Abstract][Full Text] [Related]
33. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
Crane MS; Strachan MW; Toft AD; Beckett GJ
Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.
Stanojevic M; Savin S; Cvejic D; Djukic A; Jeremic M; Zivancević Simonovic S
J Clin Lab Anal; 2009; 23(5):341-6. PubMed ID: 19774624
[TBL] [Abstract][Full Text] [Related]
35. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
[TBL] [Abstract][Full Text] [Related]
36. Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin.
Morgenthaler NG; Froehlich J; Rendl J; Willnich M; Alonso C; Bergmann A; Reiners C
Clin Chem; 2002 Jul; 48(7):1077-83. PubMed ID: 12089177
[TBL] [Abstract][Full Text] [Related]
37. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
38. Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests.
Bourrel F; Hoff M; Regis H; Courrière P; Caron P
Clin Chem Lab Med; 1998 Sep; 36(9):725-30. PubMed ID: 9804398
[TBL] [Abstract][Full Text] [Related]
39. [Response of thyroglobulin, anti-thyroglobulin antibodies, TSH, FT4 and total T3 after rhTSH stimulation in differentiated thyroid carcinoma].
Moreno Ortega E; Vallejo Casas JA; Mena Bares LM; del Real Núñez R; Maza Muret FR; Hidalgo Ramos FJ; Latre Romero JM
Rev Esp Med Nucl; 2008; 27(4):253-8. PubMed ID: 18682151
[TBL] [Abstract][Full Text] [Related]
40. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]